Evidence map›Paper›PMID 22635996›Full record

ArticleApplied and environmental microbiology2012

Reclamation of ampicillin sensitivity for the genetic manipulation of Legionella pneumophila.

Molly C Sutherland, Joseph P Vogel

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Molly C SutherlandDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Joseph P Vogel
Washington University in St. Louis · US

Funding

The molecular mechanism of Legionella type IV secretionR01AI048052 · NIAID · WASHINGTON UNIVERSITY · PI VOGEL, JOSEPH P · 2001 to 2010
$2.7M
NIAID NIH HHS AI048052NIAID NIH HHS R01 AI048052
6 · The paper itself

Abstract

Research on Legionella pneumophila, the causative agent of Legionnaires' disease, has been hampered due to the lack of selectable markers for genetic manipulation. We report the construction of a mutant strain of L. pneumophila lacking loxA, a chromosomally encoded β-lactamase, that has enhanced sensitivity to ampicillin. Also described are a method for converting Legionella strains to ampicillin sensitivity and conditions for utilizing bla as a selectable marker.

Indexed as

Ampicillinbeta-LactamasesBiomarkersDrug Resistance, BacterialGenetic EngineeringLegionella pneumophilaAmpicillinbeta-LactamasesBiomarkers

Identifiers

PMID22635996
PMCPMC3416426
OpenAlexW2058864272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.